Biomarker Testing Before Supplementing: B12, Vitamin D, Homocysteine, Ferritin, and CRP

Baseline biomarker testing is the single most effective way to rationalize a supplement protocol. Without it, dosing decisions are based on population averages rather than individual status, which leads to both undertreatment of genuine deficiencies and unnecessary supplementation of nutrients already within range. The six tests below offer the highest return on information per dollar for most adults over 40.

25-Hydroxyvitamin D

Vitamin D status is measured as serum 25(OH)D. Lab reference ranges vary, but most functional medicine and endocrinology guidelines consider optimal longevity-relevant status to be 40–60 ng/mL (100–150 nmol/L). Deficiency (below 20 ng/mL) is associated with elevated fracture risk, immune dysfunction, and all-cause mortality in epidemiological data.

Supplementation dose should be calibrated to baseline:

• Below 20 ng/mL: typically requires 3,000–5,000 IU/day to correct within 3 months
• 20–30 ng/mL: 1,500–2,000 IU/day is usually adequate for maintenance
• 30–40 ng/mL: 1,000–1,500 IU/day often sufficient

Retest after 8–12 weeks to confirm response. Toxicity (hypercalcemia) is rare below 10,000 IU/day but individual variation exists; testing prevents guesswork.

Vitamin B12 (Cobalamin)

Serum B12 is widely available but an imperfect marker of functional status because it includes inactive B12 analogues. Levels below 300 pg/mL are considered suboptimal in aging adults even if within lab reference range; below 200 pg/mL is clearly deficient. More sensitive tests — methylmalonic acid (MMA) and homocysteine — confirm functional deficiency even when serum B12 appears borderline.

B12 deficiency causes peripheral neuropathy, cognitive impairment, megaloblastic anemia, and elevated homocysteine. Age-related gastric atrophy impairs intrinsic factor production, meaning dietary B12 may not be absorbed normally. High-dose oral B12 (500–1,000 mcg/day as methylcobalamin) bypasses this via passive diffusion, as does sublingual administration.

Homocysteine

Elevated homocysteine is both a marker of methylation cycle dysfunction and an independent cardiovascular and cognitive risk factor. Levels above 15 micromol/L are associated with substantially elevated risk of cardiovascular events and dementia. Levels above 10 micromol/L may be worth addressing in adults focused on longevity.

The primary drivers of elevated homocysteine are deficiencies of B12, folate, and B6 — all of which decline with age. Supplementation with methylcobalamin (B12), methylfolate (active folate), and pyridoxine (B6) typically reduces homocysteine by 20–40% in deficient individuals. The MTHFR C677T polymorphism impairs folate conversion; those affected benefit specifically from methylfolate rather than folic acid.

Ferritin (Iron Storage)

Ferritin reflects total body iron stores. Both iron deficiency (ferritin below 30 ng/mL) and iron overload (ferritin above 200–300 ng/mL in women, above 300 ng/mL in men) carry significant risks. Iron deficiency causes fatigue, impaired cognition, and reduced exercise capacity. Iron overload — particularly undiagnosed hereditary hemochromatosis, present in roughly 1 in 250 individuals of Northern European ancestry — is hepatotoxic and cardiovascular-toxic.

Testing prevents iron supplementation in those who don't need it. Iron supplementation in iron-replete individuals increases oxidative stress and is not benign.

High-Sensitivity CRP (hs-CRP)

hs-CRP is the most accessible marker of chronic low-grade inflammation. Levels persistently above 2–3 mg/L indicate elevated inflammatory burden and are associated with cardiovascular disease, insulin resistance, and accelerated biological aging. Levels above 10 mg/L suggest acute infection or significant inflammatory disease that warrants medical evaluation.

When hs-CRP is elevated without acute illness, lifestyle factors (visceral adiposity, poor sleep, sedentary behavior, gut dysbiosis) are the primary drivers — supplements are adjunctive. Omega-3 fatty acids (EPA+DHA, 2–3 g/day) reduce hs-CRP by approximately 0.5–1 mg/L on average in randomized trials. Curcumin, magnesium, and vitamin D all have modest evidence for hs-CRP reduction when deficiency or insufficiency is present.

Thyroid Function (TSH, Free T4)

Thyroid dysfunction — both hypothyroidism and hyperthyroidism — is common in adults over 50 and substantially affects energy, weight, cardiovascular function, and cognitive clarity. Many of these symptoms overlap with supplement deficiency symptoms, making thyroid testing important for differential interpretation. An elevated TSH (above 4–5 mIU/L) with low-normal free T4 suggests hypothyroidism requiring medical management, not supplement modification.

How to Use Results

The goal is to build a short, targeted list of supplements based on confirmed insufficiency or elevated risk — not to supplement everything broadly. A practical sequence:

1. Identify deficiencies (D, B12, ferritin, magnesium via RBC level if available)
2. Address deficiencies first, before adding any enhancement-oriented supplements
3. Address elevated hs-CRP and homocysteine through combined lifestyle and targeted supplementation
4. Retest in 8–12 weeks to confirm response before proceeding to next steps

Related pages: Vitamin D3, Vitamin B12, Omega 3 Fatty Acids, Biological Aging Rate, Building Personalized Supplement Protocol, Homocysteine B12 Tmg Methylation Evidence

Evidence Limits and What We Still Need

Optimal biomarker targets for longevity — as distinct from disease prevention — are not established in long-term human trials. The vitamin D optimal level debate (30 vs. 40 vs. 60 ng/mL) is ongoing with no definitive RCT data on hard outcomes across the range. Serum magnesium poorly reflects total body status; intracellular (RBC) magnesium is better but not widely standardized. Homocysteine-lowering with B vitamins reduces the biomarker reliably but has not consistently reduced cardiovascular events in RCTs, suggesting homocysteine may be a marker rather than a cause in some populations.

Sources

1. Pludowski P, et al. "Vitamin D supplementation guidelines." J Steroid Biochem Mol Biol, 2018. https://pubmed.ncbi.nlm.nih.gov/30340411/
2. Clarke R, et al. "Homocysteine and risk of ischemic heart disease and stroke." JAMA, 2002. https://pubmed.ncbi.nlm.nih.gov/12395020/
3. Allen LH. "How common is vitamin B-12 deficiency?" Am J Clin Nutr, 2009. https://pubmed.ncbi.nlm.nih.gov/19116320/
4. Ridker PM. "From C-reactive protein to interleukin-6 to interleukin-1." Circ Res, 2016. https://pubmed.ncbi.nlm.nih.gov/26892958/
5. Pedersen BK, Saltin B. "Exercise as medicine — evidence for prescribing exercise as therapy in 26 different chronic diseases." Scand J Med Sci Sports, 2015. https://pubmed.ncbi.nlm.nih.gov/26606383/